CYLD Limits Neutrophil-Driven Psoriatic Inflammation
Inflammation · 2026
DOI: 10.1007/s10753-026-02452-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammation, 2026. Verfasst von Zhenzong Fa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, the Sixth Medical Center, Chinese PLA General Hospital, Beijing, 100048, China. Hauptthemen laut MEDLINE: Deubiquitinating Enzyme CYLD, Psoriasis, Neutrophils. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, The Innovation Cultivation Fund of the Sixth Medical Center of Chinese PLA General Hospital, The Independent Innovation Science Fund Project of the Fourth Medical Center of Chinese PLA General Hospital.
Abstract (Originalsprache)
Despite the well-recognized role of the deubiquitinase CYLD in the pathogenesis of tumors and certain inflammatory diseases, its specific function and regulatory mechanisms in psoriasis remain unclear. Thus, we first analyzed CYLD expression differences between psoriatic patients and healthy controls using skin samples from the GEO database and validated its expression dynamics in an imiquimod (IMQ)-induced mouse model. Then, we systematically evaluated the effects of CYLD deficiency on psoriasiform inflammation through histopathology, immunohistochemistry, RNA sequencing, and immunofluorescence analyses using Cyld knockout ( Cyld −/− ) mice, and employed bioinformatics approaches including CIBERSORT and Weighted Gene Co-expression Network Analysis (WGCNA) to further explore the associations between CYLD and neutrophil-related pathways and genes. The results showed that CYLD expression was significantly upregulated in lesional skin of psoriasis patients; Cyld −/− mice displayed more severe psoriasiform symptoms (enhanced epidermal thickening, increased neutrophil infiltration, significantly augmented formation of neutrophil extracellular traps [NETs]); CYLD deficiency led to excessive activation of the NF-κB signaling pathway and upregulated expression of various pro-inflammatory cytokines and chemokines. Bioinformatics analyses confirmed CYLD was closely associated with pathways related to neutrophil migration and activation. These findings lead to the conclusion that CYLD plays a crucial negative regulatory role in psoriasis by inhibiting NF-κB-mediated neutrophil activation and NETs formation, so targeted activation of CYLD may represent a promising novel therapeutic strategy for psoriasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, the Sixth Medical Center, Chinese PLA General Hospital, Beijing, 100048, China.
- Outpatient Department, the Sixth Medical Center, Chinese PLA General Hospital, Beijing, 100048, China.
- Outpatient Department, Chinese PLA General Hospital, Beijing, 100048, China.
- Department of Anesthesiology, the Fourth Medical Center, Chinese PLA General Hospital, Beijing, 100048, China. drxiequn@163.com.
- Department of Dermatology, the Sixth Medical Center, Chinese PLA General Hospital, Beijing, 100048, China. yrp809@163.com.
Förderung
- National Natural Science Foundation of China
- The Innovation Cultivation Fund of the Sixth Medical Center of Chinese PLA General Hospital
- The Independent Innovation Science Fund Project of the Fourth Medical Center of Chinese PLA General Hospital
Zitieren
APA
Fa, Z., Huang, Z., Shang, Y., Yang, Y., Xie, Q., & Yang, R. (2026). CYLD Limits Neutrophil-Driven Psoriatic Inflammation. Inflammation. https://doi.org/10.1007/s10753-026-02452-3
Vancouver
Fa Z, Huang Z, Shang Y, Yang Y, Xie Q, Yang R. CYLD Limits Neutrophil-Driven Psoriatic Inflammation. Inflammation. 2026. doi:10.1007/s10753-026-02452-3
BibTeX
@article{Fa2026,
author = {Fa, Zhenzong and Huang, Zeping and Shang, Yi and Yang, Yang and Xie, Qun and Yang, Runping},
title = {CYLD Limits Neutrophil-Driven Psoriatic Inflammation},
journal = {Inflammation},
year = {2026},
doi = {10.1007/s10753-026-02452-3}
}
EUVIMED